definiens: and shall be de emed to mean the grams of Compounds contained in the third party product ( irrespective of dosage form ) or the Licensed Product ( irrespective of dosage form ), respectively, as reflected on the label of each such unit ; and ( ii ) unlicensed unit sales shall be determined by the sales reports of IMS or any successor to IMS or any other indepe ndent marketing auditing firm selected by Eisai or its Af filiates or sublicensees and reasonably acceptable to Bukwang . If Eisai is entitled to a royalty reduction based o n unlicensed unit sales pursuant to Subsection 3.3 ( c ) for any royalty period, Eisai, its Affiliates or sublicense es shall submit the sales report of IMS or such oth er independent firm, as applicable, for the relevant royalty perio d to Bukwang, together with Eisai ’s, its Affiliates ’ or sublicensees ’ sales report for the relevant royalty period . Such sales reports for each royalty period in which Eisai is entitled to such royalty reduction shall b e submitted with the royalty report for such royalt y period submitted pursuant to Section 4.1